Anti-inflammatory and anti-coagulatory activities of caffeic acid and ellagic acid in cardiac tissue of diabetic mice

Nutrition and Metabolism

Volumn 6, Issue , 2009, Pages

  Chao, Pei Chun ^a,b   Hsu, Cheng Chin ^a,c   Yin, Mei Chin ^c  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTITHROMBIN III; ASPARTATE AMINOTRANSFERASE; CAFFEIC ACID; CATALASE; CHOLESTEROL; ELLAGIC ACID; GLUCOSE; GLUTATHIONE PEROXIDASE; GLUTATHIONE PEROXIDASE 1; INSULIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MALONALDEHYDE; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN C; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICOAGULATION; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BODY WEIGHT; CARDITIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DOWN REGULATION; DRUG TISSUE LEVEL; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEART PROTECTION; HISTOPATHOLOGY; HYPERCOAGULABILITY; HYPOLIPEMIA; INSULIN BLOOD LEVEL; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN FUNCTION; TISSUE LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION; WEIGHT REDUCTION;

MUS;

EID: 69949151713     PISSN: None     EISSN: 17437075     Source Type: Journal    
DOI: 10.1186/1743-7075-6-33     Document Type: Article

References (29)

1. Epidemiology of the diabetic heart. DN Tziakas GK Chalikias JC Kaski, Coron Artery Dis 2005 Suppl 1 S3 S10
2. Reducing cardiovascular complications of type 2 diabetes by targeting multiple risk factors. CA Reasner, J Cardiovasc Pharmacol 2008 52 136 144
3. Diabetes, hypertension and cardiovascular disease: an update. JR Sowers M Epstein ED Frohlich, Hypertension 2001 37 1053 1059
4. Catalase protect cardiomyocyte function in models of type 1 and 2 diabetes. G Ye NS Metreveli RV Donthi S Xia M Xu EC Carlson PN Epstein, Diabetes 2004 53 1336 1343
5. Metallothionein suppresses angiotensin II-induced nicotinamide adenine dinucleotide phosphate oxidase activation, nitrosative stress, apoptosis, and pathological remodeling in the diabetic heart. G Zhou X Li DW Hein X Xiang JP Marshall SD Prabhu L Cai, J Am Coll Cardio 2008 52 655 666
6. Cytokine secretion is impaired in women with diabetes mellitus. SE Geerlings EC Brouwer KC van Kessel W Gaastra RP Stolk AL Hoepelman, Euro J Clin Invest 2000 30 995 1001
7. Role of inflammatory cytokines and chemoattractants in rat model of streptozotocin-induced diabetic heart failure. J Drimal V Knezl J Navarova J Nedelcevova E Paulovicova VR Sotnikova V Snirc D Drimal, Endo Regul 2008 42 129 135
8. Phenolic compounds and antioxidant capacity of Georgia-grown blueberries and blackberries. S Sellappan CC Akoh G Krewer, J Agric Food Chem 2002 50 2432 2438
9. Determination of free and total phenolic acids in plant-derived foods by HPLC with diode-array detection. P Mattila J Kumpulainen, J Agric Food Chem 2002 50 3660 3667
10. Effects of various plant polyphenols on bladder carcinogen benzidine-induced mutagenicity. PS Makena KT Chung, Food Chem Toxicol 2007 45 1899 1909
11. Total phenol, antioxidant and free radical scavenging activities of some medicinal plants. D Prakash S Suri G Upadhyay BN Singh, Int J Food Sci Nutr 2007 58 18 28
12. Suppressive effect of caffeic acid and its derivatives on the generation of UVA-induced reactive oxygen species in the skin of hairless mice and pharmacokinetic analysis on organ distribution of caffeic acid in ddY mice. Y Yamada H Yasui H Sakurai, Photochem Photobiol 2006 82 1668 1676
13. Release of beta-endorphin by caffeic acid to lower plasma glucose in streptozotocin-induced diabetic rats. JT Cheng IM Liu TF Tzeng WC Chen S Hayakawa T Yamamoto, Horm Metab Res 2003 35 251 258
14. Antihyperglycemic and antioxidant properties of caffeic acid in db/db mice. UJ Jung MK Lee YB Park SM Jeon MS Choi, J Pharmacol Exp Ther 2006 318 476 483
15. Protein determination with the Folin phenol reagent. OH Lowry NJ Rosebrough AL Farr, J Biol Chem 1951 193 265 275
16. A manual colorimetric assay of triglycerides in serum. HG Biggs JM Erikson WR Moorehead, Clin Chem 1975 21 437 441
17. Determination of cholesterol using o-phthalaldehyde. LL Rudel MD Morris, J Lipid Res 1973 14 164 166
18. The effect of oxygen radical metabolites and vitamin E on glycosylation or proteins. SK Jain M Palmer, Free Rad Biol Med 1997 22 593 596
19. AT1 blockade prevents glucose-induced cardiac dysfunction in ventricular myocytes: role of the AT1 receptor and NADPH oxidase. JR Privratsky LE Wold JR Sowers MT Quinn J Ren, Hypertension 2003 42 206 212
20. Importance of hypercoagulability over hyperglycemia for vascular complication in type 2 diabetes. T Yamada A Sato T Nishimori T Mitsuhashi A Terao H Sagai M Komatsu T Aizawa K Hashizume, Diabetes Res Clin Prac 2000 49 23 31
21. Synergistic cofactor function of factor V and protein S to activate protein C in the inactivation of the factor VIIIafactor IXa complex - species specific interactions of components of the protein C anticoagulant system. L Shen X He B Dahlback, Thromb Haemost 1997 78 1030 1036
22. Coagulation-associated enhancement of fibrinolytic activity via a neutralization of PAI-1 activity. T Urano H Ihara Y Suzuki Y Takada A Takada, Semin Thromb Hemost 2000 26 39 42 10.1055/s-2000-9801 10805280
23. Oxidative stress and left ventricular remodeling after myocardial infarction. M Hori K Nishida, Cardiovasc Res 2009 81 457 464
24. Evidence for the regulation of levels of plasma adhesion molecules by inflammatory cytokines and their soluble receptors in type 1 diabetes. V Mohamed-Ali L Armstrong D Vlark CH Bolton JH Pinkney, J Inter Med 2001 250 415 421
25. Plasma interleukin-6 is associated with coagulation in poorly controlled patients with Type 2 diabetes. Y Aso K Okumura N Yoshida K Tayama T Kanda I Kobayashi Y Takemura T Inukai, Diabetic Med 2003 20 930 934
26. Adiposity elevates plasma MCP-1 levels leading to the increased CD11b-positive monocytes in mice. K Takahashi S Mizuarai H Araki S Mashiko A Ishihara A Kanatani H Itadani H Kotani, J Biol Chem 2003 278 46654 46660
27. Elevated monocyte chemoattractant protein-1 serum levels in patients at risk for coronary artery disease. I Martinovic N Abegunewardene M Seul M Vosseler G Horstick M Buerke H Darius S Lindemann, Circulation J 2005 69 1484 1489
28. Antioxidant and apoptosis-inducing activities of ellagic acid. DH Han MJ Lee JH Kim, Anticancer Res 2006 26 3601 3606
29. Safety assessment of ellagic acid, a food additive, in a subchronic toxicity study using F344 rats. M Tasaki T Umemura M Maeda Y Ishii T Okamura T Inoue Y Kuroiwa M Hirose A Nishikawa, Food Chem Toxicol 2008 46 1119 1124